2.要約四半期連結財務諸表及び主な注記

(1)要約四半期連結純損益及びその他の包括利益計算書

 

 

(単位:百万円)

 

 前第1四半期連結累計期間

(自 2025年4月1日

 至 2025年6月30日)

 当第1四半期連結累計期間

(自 2026年4月1日

 至 2026年6月30日)

売上収益

68,737

68,957

売上原価

△31,619

△28,970

売上総利益

37,118

39,987

販売費及び一般管理費

△21,204

△23,380

研究開発費

△6,207

△6,248

製品に係る無形資産償却費

△2,176

△2,297

その他の収益

176

71

その他の費用

△134

△16

営業利益

7,573

8,116

金融収益

627

957

金融費用

△749

△738

税引前四半期利益

7,450

8,335

法人所得税費用

△1,587

△1,135

四半期利益

5,863

7,199

その他の包括利益

 

 

純損益に振り替えられない項目:

 

 

その他の包括利益を通じて公正価値で測定する金融資産の純変動

△175

△108

純損益に振り替えられる可能性のある項目:

 

 

在外営業活動体の換算差額

3,640

3,093

その他の包括利益

3,465

2,986

四半期包括利益合計

9,328

10,185

四半期利益の帰属

 

 

親会社の所有者持分

5,878

7,194

非支配持分

△15

5

四半期利益

5,863

7,199

四半期包括利益合計の帰属

 

 

親会社の所有者持分

9,318

10,206

非支配持分

10

△22

四半期包括利益合計

9,328

10,185

1株当たり四半期利益

 

 

基本的1株当たり四半期利益(円)

17.32

22.38

希薄化後1株当たり四半期利益(円)

17.28

22.30

 

<コアベース>

コア営業利益

9,707

10,605

 

 

E0094945360参天製薬株式会社SANTEN PHARMACEUTICAL CO., LTD.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2026-04-012026-06-30Q12027-03-312025-04-012025-06-302026-03-311falsefalsefalse453602026-04-012026-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602026-04-012026-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602026-04-012026-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602026-04-012026-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-06-30jpigp_cor:RetainedEarningsIFRSMember453602025-06-30jpigp_cor:TreasurySharesIFRSMember453602025-06-30jpigp_cor:CapitalSurplusIFRSMember453602025-06-30jpigp_cor:ShareCapitalIFRSMember453602025-04-012025-06-30jpigp_cor:NonControllingInterestsIFRSMember453602025-04-012025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-04-012025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-04-012025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-04-012025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-04-012025-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-04-012025-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-04-012025-06-30jpigp_cor:TreasurySharesIFRSMember453602025-04-012025-06-30jpigp_cor:CapitalSurplusIFRSMember453602025-04-012025-06-30jpigp_cor:ShareCapitalIFRSMember453602025-03-31jpigp_cor:NonControllingInterestsIFRSMember453602025-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602025-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602025-03-31jpigp_cor:RetainedEarningsIFRSMember453602025-03-31jpigp_cor:TreasurySharesIFRSMember453602025-03-31jpigp_cor:CapitalSurplusIFRSMember453602025-03-31jpigp_cor:ShareCapitalIFRSMember453602026-06-30jpigp_cor:NonControllingInterestsIFRSMember453602026-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602026-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602026-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602026-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602025-04-012025-06-30jpigp_cor:RetainedEarningsIFRSMember453602026-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602026-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602026-06-30jpigp_cor:RetainedEarningsIFRSMember453602026-06-30jpigp_cor:TreasurySharesIFRSMember453602026-06-30jpigp_cor:CapitalSurplusIFRSMember453602026-06-30jpigp_cor:ShareCapitalIFRSMember453602026-04-012026-06-30jpigp_cor:NonControllingInterestsIFRSMember453602026-04-012026-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602026-03-31jpigp_cor:NonControllingInterestsIFRSMember453602026-04-012026-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602026-04-012026-06-30jpigp_cor:RetainedEarningsIFRSMember453602026-04-012026-06-30jpigp_cor:TreasurySharesIFRSMember453602026-04-012026-06-30jpigp_cor:CapitalSurplusIFRSMember453602026-04-012026-06-30jpigp_cor:ShareCapitalIFRSMember453602026-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602026-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602026-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602026-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602026-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602026-03-31jpigp_cor:RetainedEarningsIFRSMember453602026-03-31jpigp_cor:TreasurySharesIFRSMember453602026-03-31jpigp_cor:CapitalSurplusIFRSMember453602026-03-31jpigp_cor:ShareCapitalIFRSMember453602025-06-30jpigp_cor:NonControllingInterestsIFRSMember453602025-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602025-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember453602025-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember453602025-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602026-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602026-06-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602026-04-012026-06-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602026-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-06-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-04-012025-06-30jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602026-08-06453602026-06-30453602026-04-012026-06-30453602025-06-30453602025-04-012025-06-30453602026-03-31453602025-03-31iso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure